Primary Peritoneal Carcinoma Active Not Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02788708Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerTreatment
NCT02661815A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological CancerTreatment